HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
1 - 2 of 2
ICON 3 is a prospective, open label, randomized, multi-center phase 3 clinical trial comparing eltrombopag with the enrolling physician’s choice of front line therapy.
Related PI: Michele Lambert, MD, MSTR
Related Conditions: Blood Disorders, Immune Thrombocytopenia, Autoimmune, Autoimmune Disorders, Bleeding
The Panzyga Study is looking at a potential medicine (experimental drug) to see if it can result in increasing platelet counts and may potentially treat ITP.
Related Conditions: Hematology, Immune Thrombocytopenia, Clinical Trials, Autoimmune, Bleeding